Korelitz B I
Department of Medicine, Lenox Hill Hospital, NYU School of Medicine, NY 10021, USA.
Gastroenterologist. 1995 Jun;3(2):141-52.
I present the progressive development of treatment with immunosuppressive drugs for Crohn's disease and ulcerative colitis, starting with rationale, failure of corticosteroids for maintenance, early observations, controlled trials, collaborations, toxicity (including fear of neoplasms), and considerations in pregnancy. Emphasis is on 6-mercaptopurine and azathioprine. Observations on methotrexate and cyclosporine are included, as well as advice on when to initiate immunosuppressive therapy, what is occurring currently, and what is expected to occur in the near future.
我介绍了用于克罗恩病和溃疡性结肠炎的免疫抑制药物治疗的逐步发展,从理论依据、皮质类固醇维持治疗的失败、早期观察、对照试验、合作、毒性(包括对肿瘤的担忧)以及妊娠相关考虑因素开始。重点是6-巯基嘌呤和硫唑嘌呤。还包括对甲氨蝶呤和环孢素的观察,以及关于何时开始免疫抑制治疗、目前正在发生什么以及在不久的将来预计会发生什么的建议。